Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.80)
# 725
Out of 5,124 analysts
485
Total ratings
43.63%
Success rate
10.97%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLSI Greenwich LifeSciences | Maintains: Buy | $39 → $50 | $21.01 | +137.98% | 9 | Dec 30, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $24.18 | +32.34% | 5 | Dec 29, 2025 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $4 → $1.5 | $0.62 | +143.11% | 8 | Dec 26, 2025 | |
| BEAT HeartBeam | Maintains: Buy | $2.5 → $5.5 | $2.40 | +129.17% | 2 | Dec 10, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $19 → $21 | $12.14 | +73.05% | 30 | Dec 8, 2025 | |
| AXGN Axogen | Maintains: Buy | $26 → $39 | $32.73 | +19.16% | 3 | Dec 5, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $98 → $185 | $159.96 | +15.65% | 22 | Dec 1, 2025 | |
| BNGO Bionano Genomics | Maintains: Buy | $11 → $7 | $1.53 | +357.52% | 3 | Nov 24, 2025 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $4.95 | +81.82% | 21 | Nov 24, 2025 | |
| CODX Co-Diagnostics | Reiterates: Neutral | n/a | $0.17 | - | 24 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $3.41 | +163.93% | 11 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $1.5 | $0.26 | +486.85% | 4 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.03 | +244.83% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.70 | +471.35% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $36 | $23.35 | +54.18% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $8.03 | -12.83% | 5 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $49.00 | +40.82% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $19.97 | +110.32% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $59.05 | +50.72% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.42 | +252.11% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $17.08 | -0.47% | 20 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.61 | +309.77% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $14.41 | +135.95% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.56 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.07 | +238.16% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.12 | +124.36% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.15 | +140.96% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.97 | +407.61% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.23 | +225.20% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.51 | +496.03% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.98 | +101.01% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $18.27 | +25.89% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $12.84 | +24.61% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $15.44 | +16.58% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $18.84 | +32.70% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.26 | +138.10% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.35 | +767.55% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.14 | +1,301.87% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.12 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $1.75 | +28,471.43% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $0.45 | +24,481.01% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $11.43 | +319.95% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $99.74 | -80.95% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.78 | - | 2 | Apr 16, 2020 |
Greenwich LifeSciences
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $21.01
Upside: +137.98%
BioLife Solutions
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $24.18
Upside: +32.34%
Lexaria Bioscience
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.62
Upside: +143.11%
HeartBeam
Dec 10, 2025
Maintains: Buy
Price Target: $2.5 → $5.5
Current: $2.40
Upside: +129.17%
Ocular Therapeutix
Dec 8, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $12.14
Upside: +73.05%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $32.73
Upside: +19.16%
Belite Bio
Dec 1, 2025
Maintains: Buy
Price Target: $98 → $185
Current: $159.96
Upside: +15.65%
Bionano Genomics
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.53
Upside: +357.52%
Alpha Tau Medical
Nov 24, 2025
Reiterates: Buy
Price Target: $9
Current: $4.95
Upside: +81.82%
Co-Diagnostics
Nov 24, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.17
Upside: -
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $3.41
Upside: +163.93%
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.26
Upside: +486.85%
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $2.03
Upside: +244.83%
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.70
Upside: +471.35%
Nov 14, 2025
Maintains: Buy
Price Target: $54 → $36
Current: $23.35
Upside: +54.18%
Nov 13, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $8.03
Upside: -12.83%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $49.00
Upside: +40.82%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $19.97
Upside: +110.32%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $59.05
Upside: +50.72%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $17.08
Upside: -0.47%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.61
Upside: +309.77%
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $14.41
Upside: +135.95%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.07
Upside: +238.16%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $3.12
Upside: +124.36%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.15
Upside: +140.96%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $1.97
Upside: +407.61%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.23
Upside: +225.20%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $1.51
Upside: +496.03%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.98
Upside: +101.01%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $18.27
Upside: +25.89%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $12.84
Upside: +24.61%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $15.44
Upside: +16.58%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $18.84
Upside: +32.70%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.26
Upside: +138.10%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.35
Upside: +767.55%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.14
Upside: +1,301.87%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.12
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $1.75
Upside: +28,471.43%
Feb 21, 2024
Reiterates: Buy
Price Target: $110
Current: $0.45
Upside: +24,481.01%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $11.43
Upside: +319.95%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $99.74
Upside: -80.95%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.78
Upside: -